DSG in the News

September 30, 2020 — Reven is planning to initiate a randomized, double-blind, placebo-controlled, multi-institutional clinical trial of its lead anti-inflammatory/anti-oxidant investigational drug product Rejuveinix (RJX) in the treatment of COVID-19. The upcoming clinical trial is designed to evaluate the safety and efficacy of RJX in COVID-19 patients.

Reven today announced that it selected DSG, Inc., a leading global eClinical services provider, for all aspects of clinical trial data management during its upcoming COVID-19 study. DSG will work directly with the Reven team, facilitating the real-time process optimizations needed to make data management more efficient in a proactive electronic data capture (EDC) environment. DSG, with its eCaseLink platform, will provide the data management tools for Reven to achieve its high-quality data collection, management and analysis goals. Reven will also utilize the Interactive Response Technology (IRT) of DSG to manage randomization in the upcoming study.

March 21, 2018 — As alluded to above, Lourdes has had consistently good athletic programs throughout the decades. But what makes the recent state title game appearances even more special is that Lourdes as an institution and local education choice has been strengthened in recent years.

This past fall, the Coal Township Catholic school celebrated a “million-dollar day” in honoring alumnus Tony Varano for spearheading a Education Income Tax Credit drive that since 2012 has generated more than $1 million to help more children attend Lourdes.

The Witness — November 24, 2017 — The numbers tell the story. Five years ago, Our Lady of Lourdes Regional School in Coal Township was in a dire position. There were 350 students enrolled in the PreK-12 school, and area parishes were funding 40 percent of its operating budget. The school was losing students after their eighth and ninth grade year, as tuition costs increased. EITC funding to support tuition assistance for families was at $14,000. There were rumors that the school would close. Lourdes needed a lifeline.

Working with school administrators, businessman and graduate Tony Varano developed a business plan, which included a push for more companies to get involved in the EITC program. An acronym for Pennsylvania’s Educational Improvement Tax Credit program, it offers tax credits to eligible businesses contributing to a scholarship organization, thus assisting families with financial assistance and retaining and attracting students in the school that best meets their needs.

November 10, 2017 — “School choice” remains a divisive issue, but it has manifested itself in our community through a simple yet effective — and politically neutral — program called the Educational Improvement Tax Credit (EITC). Pennsylvania enacted the EITC in 2001, but it was five years ago when what some would likely consider a miracle began to impact Our Lady of Lourdes Regional School.

Lourdes alumnus Tony Varano and the alumni foundation focused on using the EITC to help the Coal Township school as its battle to survive was compounded by a tough economy and slumping local funds.

November 09, 2017 — COAL TOWNSHIP — Wednesday was a million dollar day at Our Lady of Lourdes Regional School. The Most Rev. Ronald Gainer, bishop of the Diocese of Harrisburg, joined school officials, faculty, students and staff in honoring Tony Varano, a Lourdes graduate who has donated $1,061,000 to the Earned Income Tax Credit (EITC) program for tuition assistance since 2012.

Varano, CEO of DSG Inc. in Malvern, a software company for life sciences, said he was happy to financially support his alma mater by giving hundreds of students an opportunity to attend Lourdes. He pointed out that enrollment at Lourdes grew from approximately 350 to 530 students (51.4 percent) since 2012, which averages to about 35 new students each year. Students in pre-kindergarten through 12th grade attend classes at the school.

Malvern, Pa., March 04, 2015 — Many years before the FDA offered its eSource Guidance in September 2013, Sirion Therapeutics launched its first two pivotal Phase III studies using entirely electronic source data collection. In those trials for the safety and efficacy of Difluprednate for the management of inflammation following ocular surgery, Kim McLeod, former Vice President of Clinical Operations at Sirion and currently Director, Prospective Research at Xcenda, said, “Electronic source made the most practical and economic sense; however in researching the topic, we discovered a lack of FDA guidance, an absence of industry case studies, and no subject matter expertise such as consultants with experience in submitting a 100% electronic source study to the Agency.”

Malvern, Pa., Sept. 18, 2013 — The Wall Street Journal reports biopharmaceutical firm Kythera Biopharmaceuticals Inc. reported positive Phase III results on two submental fat treatment trials. On Monday, the company announced the trials for its ATX-101 injectable, designed to reduce fat in the chin, had met all primary and secondary endpoints.

Reuters (9/17, Siddiqui) reports that more than 1,000 patients were enrolled in the two studies, which were conducted in Canada and the US.

Malvern, Pa., March. 12, 2013 Listen to the Federal News Radio interview with Tony Varano who discussed the latest developments in clinical trials, data management and regulatory issues on Fed Tech Talk, with award-winning host John Gilroy.

Tony Varano offered insights on how clinical trials are evolving, where the FDA continues its crucial role and how software companies like DSG are a key to success for pharmaceutical, biotech and medical device industries.

Malvern, Pa., Oct. 08, 2012 — Auxilium Pharmaceuticals, a leading company focused on products for urology and sexual health, has selected DSG’s eCaseLink™ as its provider for electronic data capture (EDC). Auxilium will also use DSG’s interactive web response system (IWRS) and clinical data management services for supporting the submission of a supplemental Biologics License Application (sBLA) to the FDA for their XIAFLEX® program in Peyronie’s Disease by end of 2012.

Malvern, Pa., April 23, 2012— Ariosa Diagnostics, a molecular diagnostics company focused on prenatal testing, has chosen to use DSG’s eCaseLink EDC (electronic data capture) system for the NEXT (Non-Invasive Chromosomal Examination of Trisomy) study.

Exton, Pa., Oct. 19, 2011— Frontage Laboratories, Inc. a global pharmaceutical contract research organization, now offers clients faster clinical trial data collection and increased accuracy through advanced electronic data capture (EDC) technology. Clinical research clients will benefit from a new strategic partnership between Frontage and DSG Inc., a pioneer of EDC solutions for pharmaceutical and biotech companies. Study coordinators working with Frontage Clinical Services worldwide now have access to DSG’s eCaseLink 8.0 EDC software system.